Page last updated: 2024-08-24

valsartan and Nasopharyngitis

valsartan has been researched along with Nasopharyngitis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antonio, ZL; Glazer, RD; Kang, HG; Lou-Meda, R; Stiller, B; Tan, M; Valentin, MA; Wang, L; Yap, HK; Zielinska, E	1
Glazer, R; Jin, J; Philipp, T; Pospiech, R; Schneider, H; Smith, TR; Wernsing, M; Yen, J	1

Trials

2 trial(s) available for valsartan and Nasopharyngitis

Article	Year
Long-term safety and tolerability of valsartan in children aged 6 to 17 years with hypertension. Pediatric nephrology (Berlin, Germany), 2019, Volume: 34, Issue:3 Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Child; Cough; Creatinine; Drug Therapy, Combination; Female; Fever; Glomerular Filtration Rate; Headache; Humans; Hypertension; Male; Nasopharyngitis; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Serum Albumin, Human; Severity of Illness Index; Time Factors; Treatment Outcome; Valsartan	2019
Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hyperten Clinical therapeutics, 2007, Volume: 29, Issue:4 Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Headache; Humans; Hypertension; Male; Middle Aged; Nasopharyngitis; Tetrazoles; Valine; Valsartan	2007

Article

Year

Long-term safety and tolerability of valsartan in children aged 6 to 17 years with hypertension.

Pediatric nephrology (Berlin, Germany), 2019, Volume: 34, Issue:3

Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Child; Cough; Creatinine; Drug Therapy, Combination; Female; Fever; Glomerular Filtration Rate; Headache; Humans; Hypertension; Male; Nasopharyngitis; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Serum Albumin, Human; Severity of Illness Index; Time Factors; Treatment Outcome; Valsartan

2019

Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hyperten

Clinical therapeutics, 2007, Volume: 29, Issue:4

Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Headache; Humans; Hypertension; Male; Middle Aged; Nasopharyngitis; Tetrazoles; Valine; Valsartan

2007